Research Project · Health, Medicine, Oncology
Clinical Trials Investigated by Dr. Alexander Drilon
Memorial Sloan Kettering Cancer Centerwww.mskcc.org (opens in a new tab)Catalog updated
No deadline listed
- Amount
- Not listed
- Program type
- Research Project
- Field
- Health, Medicine, Oncology
- Eligible career stages
- Not listed
About this program
Memorial Sloan Kettering Cancer Center is conducting multiple clinical trials led by Dr. Alexander Drilon, focusing on advanced solid tumors and non-small cell lung cancer. These Phase 1/2 studies investigate the safety, efficacy, and pharmacokinetics of investigational drugs such as BBI-355, EP0031, NVL-520, NVL-655, TPX-0005, and cabozantinib. Eligibility criteria vary by trial, and interested patients should contact MSK for specific details on enrollment and participation requirements.
In FundFit
Full eligibility
Source announcement
Similar programs
These details are in FundFit.